Annexin A2 (C-terminal region) Antibody, IgG1, Clone: [M298], Unconjugated, Mouse, Monoclonal

Catalog Number: BSS-BSM-70336M
Article Name: Annexin A2 (C-terminal region) Antibody, IgG1, Clone: [M298], Unconjugated, Mouse, Monoclonal
Biozol Catalog Number: BSS-BSM-70336M
Supplier Catalog Number: bsm-70336M
Alternative Catalog Number: BSS-BSM-70336M-100
Manufacturer: Bioss
Host: Mouse
Category: Antikörper
Application: IHC, IP, WB
Species Reactivity: Gallus, Human, Mouse, Rat
Conjugation: Unconjugated
Alternative Names: Lipocortin, Calpactin 1, Annexin II
The Annexin family is composed of at least thirteen mammalian genes (Annexin A1-13). These proteins are characterized by a conserved core domain which binds to phospholipids in a Ca2+-dependent manner and a unique amino terminal region which may confer binding specificity. Annexins have roles in membrane fusion, endocytosis, secretion, and repair. Annexin A1 binds to cellular membranes in a calcium-dependent manner, promotes membrane fusion and endocytosis, and has been implicated as an anti-inflammatory mediator. Annexin A2 is a cytoskeletal calcium-dependent phospholipid binding protein, which has been shown to be a mediator of corticosteroid activity, a substrate for serine/threonine kinases and growth regulated tyrosine kinases, and may play a role in secretion. Annexin A5 is a PKC inhibitor, directly interacts with VEGFR2 receptor, and binds phosphatidylserine to inhibit blood coagulation. Annexin A6 reverses transformation of A431 cells after overexpression, and this effect may involve annexin A6 targeting of p120 RasGAP to the plasma membrane to inactivate Ras.
Clonality: Monoclonal
Clone Designation: [M298]
Isotype: IgG1
UniProt: P07355
Buffer: PBS + 1 mg/ml BSA, 0.05% NaN3 and 50% glycerol
Source: Clone M009 was generated from a proprietary antigen related to human Annexin A2 in MDA-MB-231 breast cancer cell line.
Target: Annexin A2 (C-terminal region)
Application Dilute: WB(1:300-5000), IP(1-2ug), IHC()